$10 Million Lawsuit on Actos Bladder Cancer

According to court documents, on June 12th, 2012, New York woman Wanda Heavey filed a lawsuit in New York Eastern District Court (case no. 2:2012cv02945) alleging she suffered bladder cancer after taking Actos for five years. Actos is a type 2 diabetes drug, manufactured by Takeda Pharmaceutical Industries Limited and promoted as decreasing insulin resistance. In July 2012 the lawsuit was transferred to the MultiDistrict Litigation Western District of Louisiana (MDL 2299) for all federal claims alleging injury caused by Actos. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Actos severe adverse events. http://www.attorneyone.com/actos-lawsuit/

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Actos: severe adverse events threat

Actos: severe adverse events threat

She started taking Actos in 2005 and she continued till December 2010 when she was diagnosed with bladder cancer

San Diego, CA (PRWEB) November 01, 2012

The media spotlight is often a double-edged sword. No one knows this better than Wanda Heavey and people who suffer from Actos Side Effects. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

According to court documents, on June 12th, 2012, New York woman Wanda Heavey filed a $10 million lawsuit in New York Eastern District Court (case no. 2:2012cv02945) alleging she suffered bladder cancer after taking Actos for five years. Actos is a type 2 diabetes drug, manufactured by Takeda Pharmaceutical Industries Limited and promoted as decreasing insulin resistance. In the lawsuit Heavey claims she started taking Actos in 2005 and she continued till December 2010 when she was diagnosed with bladder cancer. In July 2012 the lawsuit was transferred to the MultiDistrict Litigation Western District of Louisiana (MDL 2299) for all federal claims alleging injury caused by Actos.

Findings of the study published on July 3rd 2012, in the Canadian Medical Association Journal, revealed that Actos (pioglitazone) is linked to increased risk of bladder cancer.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of severe adverse events from Actos, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Actos remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On August 17th, 2012, the US FDA announced it approved the first generic version of Actos (pioglitazone hydrochloride) tablets, by Mylan Pharmaceuticals, for 15 milligram, 30 mg and 45 mg tablets.

AttorneyOne.com has further information on Actos lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/10/prweb10066124.htm.